Jason discusses the benefits of accessing patient information across clinical contexts. He introduces us to the Wolters Kluwer drug data solutions. These solutions promote interoperability and help healthcare businesses meet regulations related to health information exchange.
To learn more, download the Wolters Kluwer interoperability stories ebook.
Read on for Jason’s insights.
Enhance Patient Care And Cost Savings By Improving Data Exchange Within The Systems You Already Have
By Jason Coles, Senior Product Manager for Clinical Effectiveness, Wolters Kluwer, Health.
Surescripts 2019 National Progress Report, 80% of all prescriptions are now delivered electronically.
Over the past few decades, there have been extensive efforts to develop the policy and technical infrastructure required for clinical information exchange. Still, a 2020 report by the Healthcare Information and Management Systems Society (HIMSS) counted more than 40 different interoperability standards development organizations (SDOs) in operation. So, while healthcare organizations understand that interoperability is important, it is difficult to navigate the evolving array of mandates and standards and know where to invest.
Starting with the basic data backbone you already have—drug descriptive data, therapeutic classification systems, and drug pricing data—you can target care and cost interventions based on your goals that will enable you to stay current with industry standards. Only a clinical drug data solution that adheres to most interoperability standards and enables seamless data integration and processes within your information systems can get you there.
For example, current vocabularies and terminologies in Medi-Span® can be added to target the following business goals:
- Building Surescripts certification-ready e-prescribing capabilities that meet industry standards
- Creating effective patient allergy screening processes to enhance safety and stay ahead of new mandates
- Conducting research to gain insights into claims and medication use to steer quality and cost initiatives
Achieving Surescripts certification is vital for any business that sends and/or receives electronic messages in accordance with industry standards and offers open choice for medication selection and dispensing. Providers look for Surescripts certification in order to participate in shared information networks and meet Office of the National Coordinator of Health Information Technology (ONC) technology standards, which helps them earn incentives and avoid penalties from the Centers for Medicare and Medicaid Services.
By implementing a streamlined and advanced RxNorm mapping strategy, electronic health record and pharmacy system management vendors position themselves competitively and allow their clients to pursue critical Surescripts certification while adhering to strict patient safety protocols and efficient e-prescribing workflows.
ONC recently designated the vocabulary of SNOMED CT® as the standard for mapping allergic reaction values. A sophisticated, bidirectional mapping system incorporating SNOMED CT allergen concepts can help ensure that your business can receive SNOMED data, perform timely and relevant patient safety screenings regarding drug allergies, and align that information with your internal processes. SNOMED CT data is freely available, but manually mapping and maintaining it is a time-consuming and labor-intensive process that many businesses cannot afford to undergo, particularly when advanced and streamlined data implementation is available.
Limited insights into care and prescribing patterns among health plan members or patients can make it difficult to understand how well your business is supporting appropriate care. Something as seemingly simple as an ICD-10 interoperability strategy can be the key to revealing trends in claims and medication use data and discovering where there may be inefficiencies.
Claims, medication use, and diagnoses are not unified under common coding and identification. But with bidirectional mapping between ICD-10 and an identifier like the Medi-Span GPI, you create a crucial link to group diseases and conditions for study and analysis.
Pinpointing the areas where investments in interoperability data can have the greatest impact on your organization is the first step in an ongoing journey. Standards, security, and technology are always evolving. To learn more about Medi-Span interoperability solutions, visit our website.
Download the Wolters Kluwer Interoperability Stories ebook.
Sponsored guest posts are bylined articles that are screened by Drug Channels to ensure a topical relevance to our exclusive audience. These posts do not necessarily reflect our opinions and should not be considered endorsements.
To find out how you can publish a guest post on Drug Channels, please contact Paula Fein (email@example.com).